- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01409525
Rate of Microbial Colonization Over Native Calcified Cardiac Valves
August 3, 2011 updated by: Rambam Health Care Campus
Observational, Prospective, Exploratory Study to Evaluate the Rate of Microbial Colonization Over Native Calcified Cardiac Valves
The purpose of this observational, exploratory study in patients undergoing any cardiac valve replacement or repair is to assess the rate of bacterial colonization over native degenerative calcified cardiac valves.
Study Overview
Status
Unknown
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Haifa, Israel
- Rambam Health Care Campus
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Up to 200 eligible adult subjects, scheduled to undergo elective cardiac surgery in RAMBAM medical center.
Description
Inclusion Criteria:
- Written informed consent must be obtained from the subject or his/her legal guardian before any assessment is performed
- Male or Female subject, 50 years or older
- Subjects are scheduled to go through any cardiac valve replacement or repair due to degenerative calcified process. For control, subjects with no evidence of valve disease
Exclusion Criteria:
- Subjects have an established or indicated history of IE.
- Subjects have complaint that might indicate IE- intermittent fever and physical finding according to IE diagnosis criteria (not including a heart murmur)
- Subjects are current users or have a close history of drug abuse
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
cardiac surgery patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To asses the rate of bacterial colonization over degenerative cardiac valves and to discover whether there is a link to a specific micro-organism.
Time Frame: Patients will be followed for the duration of their hospitalization, average of 5 days.
|
Patients will be followed for the duration of their hospitalization, average of 5 days.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation between baseline demographic, clinical and laboratory parameters to degenerative cardiac valve disease
Time Frame: Patients will be followed for the duration of their hospitalization, average of 5 days.
|
Baseline demographic, clinical and laboratory parameters such as age, gender, medical history, complete blood count and biochemistry profile will be compared between research group (degenerative cardiac valve disease) and control group (Isolated coronary artery bypass graft surgery patients) by means of multivariate analysis and pattern recognition techniques.
|
Patients will be followed for the duration of their hospitalization, average of 5 days.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (ANTICIPATED)
July 1, 2012
Study Completion (ANTICIPATED)
October 1, 2012
Study Registration Dates
First Submitted
July 28, 2011
First Submitted That Met QC Criteria
August 3, 2011
First Posted (ESTIMATE)
August 4, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
August 4, 2011
Last Update Submitted That Met QC Criteria
August 3, 2011
Last Verified
August 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RMB-0233.CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Degenerative Cardiac Valve Disease
-
Heart Center Leipzig - University HospitalUniversity of Leipzig; Helios Health Institute GmbHRecruitingDegenerative Aortic Valve DiseaseGermany
-
Michele De BonisCompletedDegenerative Mitral Valve DiseaseItaly
-
Cedars-Sinai Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingDegenerative Mitral Valve DiseaseUnited States
-
University Health Network, TorontoUnknownDegenerative Mitral Valve Disease
-
Tomsk National Research Medical Center of the Russian...Active, not recruitingDegenerative Mitral Valve DiseaseRussian Federation
-
Sheng LiuRecruitingDegenerative Mitral Valve DiseaseChina
-
Jenscare ScientificNot yet recruitingMitral Valve Regurgitation | Degenerative Mitral Valve Disease
-
Pipeline MedicalCompletedMitral Valve Regurgitation | Degenerative Mitral Valve DiseaseSerbia, Georgia, Paraguay
-
Peijia Medical Technology (Suzhou) Co., Ltd.RecruitingMitral Regurgitation | Degenerative Mitral Valve DiseaseChina
-
Polares Medical SATerminatedDegenerative Mitral Valve DiseaseUnited States